Remote Patient Monitoring (RPM) and the future of patient data collection
Alicyn Campbell
Founder and CEO @Stealth | Building AI Products to Increase the Quality and Efficiency of Healthcare | Former VP/Head Digital Health Oncology R&D at AstraZeneca; Chief Scientific Officer, Evinova, AZ
Continued technology advances in Bluetooth enabled connected devices, the ability to collect temporally relevant data at scale, and advances in ML/AI and advanced analytics are allowing us to continually improve the patient experience in cancer care, from personalized medicine through to remote patient monitoring (RPM) solutions used as adjuncts to treatment. These solutions can help to keep patients on treatment longer and?reduce suffering from treatment related adverse events.
In my role leading the Digital Health Oncology R&D team, building digital products for use within clinical trials as well as routine care at?AstraZeneca, I see first-hand the immense benefit that adjunctive RPM digital solutions bring to clinical trials & patient care.
The increased visibility of patient symptoms in real-time can allow for enhanced accuracy of diagnosis, increased speed of targeted interventions and in some cases a reduction in disease progression. These elements coupled with educational materials and guidelines for patient self-care and targeted HCP alerts all have the potential to improve patient outcomes.
?Considerations when deploying new digital solutions include ensuring that they are suitable for use across all age groups. Adequate training on the required technologies before adoption into clinical trials is essential to ensure: data collected is reliable, enables participants to feel empowered about their care, provides a powerful feedback loop where data is shared with the patients, allowing self-management of side effects through continuous feedback and guidance. This reduces the burden for patients & providers.?
?We also need to continue to follow the science! Gold standard clinical evidence should underpin everything: defining context of use, tolerability, reliability, ensuring alerts are appropriate and thoughtful algorithm development.?
Ensuring user workflow acceptance is key, we need to make these solutions easy to adapt and import into all health systems.
领英推荐
?The more we use these new technologies the more reliable the data will be and patients, healthcare providers and health systems will become more comfortable using them. We need to ensure we’re increasing efficiencies and fidelity and not adding burden.?
?There’s a huge opportunity to improve clinical care and there have been massive advances of their use in clinical trials & assessing patient experience but now we need to take it to the next level to ensure patients have access to digital therapeutics and technologies once the trial has completed to support ongoing & improved care.
?Digital adjuncts should and will be prescribed with every new therapy, customized to a patient’s medical history, risk profile, personal objectives for treatment, and their treatment plan, reducing suffering and improving health outcomes. This is the future of care!
?
Hospitalist
1 年Great article I am a family physician how can I involve in RPM?
Senior Medical Scientist at Reckitt
1 年Fabulous to read about this, Alicyn. Digital technologies like these must also be a real boost to patient reassurance and confidence, as well as to health and therapeutic literacy. What a great area to be innovating in!
Marketing Manager for leading digital health platform, Clintouch.
1 年Really interesting piece, thank you for sharing. RPM solutions can have huge benefits for patient care, including reducing need for hospitalisation, improving access to care and probably the biggest one, being able to receive care at home. You may find this survey interesting to read around how patients really feel about digital health tech: https://www.dhirubhai.net/pulse/patient-perspective-how-do-really-feel-digital-health-tech
Thanks Alicyn Campbell - we follow a very similar philosophy with our digital biomarkers and measures: "...follow the science! Gold standard clinical evidence should underpin everything...". Wishing you and your patients all the best as you raise the standard of care with digital solutions.
Digital Transformation of Life Sciences | Innovation Management | Digitalisation of Clinical Development | Strategic Execution | Fusing medicine and technology (DTx-SaMD) | Advisor | Exec. Coach | Mentor
1 年Totally agree Alicyn Campbell ! Digital Heath Technologies (DHTs) holds the potential to deliver real-time insights to treatment effects as well as therapeutic adjustments. I believe the day and age of “go take the drug and hope for the best” are over when all interested parties (patients, HCPs and Payers) share an interest in optimal use of interventions. I appreciate the V3 (verification, analytical and clinical validation) of Digital Medicine Society (DiMe), augmented with insights into “where” in terms of health system phenotype for #remotepatientmonitoring .